Qingdao Haier Biomedical Co Ltd. Stock Analysis 688139.SS

Qingdao Haier Biomedical Co., Ltd. engages in the development of biotech products. The company is headquartered in Qingdao, Shandong and currently employs 2,945 full-time employees. The company went IPO on 2019-10-25. The firm's main businesses include: providing biomedical low-temperature storage solutions covering the whole temperature range for scenarios such as sample safety, drug and reagent safety, vaccine safety and blood safety, as well as automatic, intelligent and comprehensive upgrading based on user needs, and providing integrated solutions for Internet of Thing (IoT) scenarios covering a variety of biosafety products. The firm's products are sold to domestic and overseas markets.